AMRN - アマリン (Amarin Corporation plc)

AMRNのニュース

   Investing in Amarin Corporation plc (AMRN) might be an excellent idea, but the stock is currently overvalued/undervalued  2022/09/06 12:32:00 US Post News
As of Friday, Amarin Corporation plc’s (NASDAQ:AMRN) stock closed at $1.21, up from $1.17 the previous day. While Amarin Corporation plc has overperformed by 3.42%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMRN fell by -77.59%, with highs and lows ranging from $5.52 to $1.09, […]
   12-Month Price Target For Amarin Corporation plc (NASDAQ:AMRN) Now Sits At $9.00  2022/09/02 11:00:00 Marketing Sentinel
In last trading session, Amarin Corporation plc (NASDAQ:AMRN) saw 8.36 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price level of $1.17 trading at -$0.01 or -0.85% at ring of the bell on the day assigns it a market valuation of $482.93M. That closing price of AMRN’s stock is … 12-Month Price Target For Amarin Corporation plc (NASDAQ:AMRN) Now Sits At $9.00 Read More »
   Amarin Corporation plc : Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference  2022/08/30 13:00:00 Investegate
1:00 PM: Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference
   Amarin to Present at H.C. Wainwright’s 24th Annual Global Investment Conference  2022/08/30 12:00:00 GlobeNewswire
DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022.
   Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers  2022/08/28 09:53:00 Finanz Nachrichten
-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysi…
   Why Amarin Stock Is Sinking Today  2022/07/01 15:40:33 The Motley Fool
Investors continue to process disappointing data that was published on Thursday.
   AMRN stock in focus after latest data on Vascepa (NASDAQ:AMRN)  2022/06/30 20:34:32 Seeking Alpha
Commercial-stage biotech Amarin Corporation (AMRN) announced on Thursday that serum samples of patients treated with its heart disease drug icosapent ethyl ((IPE)) had only…
   AMRN stock drops after concerns over cardiovascular therapy (NASDAQ:AMRN)  2022/06/30 17:40:32 Seeking Alpha
The shares of commercial-stage biotech Amarin Corporation (AMRN) dropped sharply on Thursday after Stat News raised concerns over the effectiveness of its heart disease…
   Amarin Corporation plc (AMRN) Has Great Growth Outlook For 2022  2022/06/29 11:00:00 Marketing Sentinel
Amarin Corporation plc (NASDAQ:AMRN) has a beta value of 1.81 and has seen 2.15 million shares traded in the last trading session. The company, currently valued at $761.20M, closed the last trade at $1.85 per share which meant it lost -$0.07 on the day or -3.65% during that session. The AMRN stock price is -222.7% … Amarin Corporation plc (AMRN) Has Great Growth Outlook For 2022 Read More »
   Amarin Corporation plc (NASDAQ: AMRN) Stock Seems Like A Good Option  2022/06/24 12:00:00 Stocks Register
Amarin Corporation plc (NASDAQ:AMRN) shares, rose in value on Thursday, 06/23/22, with the stock price up by 5.85% to the previous day’s close as strong demand from buyers drove the stock to $1.99. Actively observing the price movement in the last trading, the stock closed the session at $1.88, falling within a range of $1.875 … Amarin Corporation plc (NASDAQ: AMRN) Stock Seems Like A Good Option Read More »
   Pharma company Amarin has a key asset and a big decision. How Sarissa Capital can help it move forward  2022/01/29 13:45:55 CNBC
Activist fund Sarissa brings extensive knowledge and deep contacts in the health-care space, which could come in handy at Amarin.
   Amarin (AMRN) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference  2022/01/12 21:12:29 Seeking Alpha
   Amarin Corporation plc (AMRN) Fell Out Of Favor With Hedge Funds?  2022/01/12 17:11:18 Insider Monkey
As we already know from media reports and hedge fund investor letters, hedge funds delivered their best returns in a decade.
   Amarin Corporation plc (AMRN) CEO Karim Mikhail Presents at 40th Annual J.P. Morgan Healthcare Conference (Transcript)  2022/01/11 16:37:02 Seeking Alpha
   Amarin sees Q4 and FY21 revenue below consensus; shares down 3% (NASDAQ:AMRN)  2022/01/10 12:57:04 Seeking Alpha
Amarin (AMRN) provides a business update, including preliminary full-year 2021 revenue results. Q4 and FY 2021 total net revenues are estimated to be ~$140M (consensus $156.02M)

calendar